Etrasimod

Name: Etrasimod
Availability: etrasimod-357369.html

Category:Active Pharmaceutical Ingredients > Other Anti-Infective Drug
Product Name:Etrasimod
CAS No.:1206123-37-6
Standard:In-house Standards
Price(USD):Negotiable
Company:Shenzhen Haorui Pharmatech Co., Ltd.

Send Inquiry

Favorites

Similar Products

Sulfamethoxazole

Halquinol 1

Adefovir Dipivoxil Tablets

Azithromycin

Amantadine Hydrochloride

Ciprofloxacin HCL

Phenol

Posaconazole(Form Ⅰ)

VORICONAZOLE

Naproxen base

Basic Info

Grade: Pharmaceutical Grade

Factory Location: Hubei

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no

Payment Terms: L/C

Etrasimod is a synthetic next-generation selective Sphingosine 1-phosphate (S1P) receptor modulator that targets the S1P1,4,5 with no detectable activity on S1P2 and S1P3 receptors. Etrasimod was approved on October 13, 2023, by the FDA under the brand name VELSIPITY for the treatment of adults with moderately to severely active ulcerative colitis.

Send your message to this supplier

From:
To:
Shenzhen Haorui Pharmatech Co., Ltd.
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification:

Other Products from this supplier
More>>

Granisetron Hydrochloride

Dasatinib monohydrate

Flumazenil

Docetaxel anhydrous

Epinastine Hydrochloride

Desvenlafaxine succinate

Neostigmine Methylsulfate

Venlafaxine hydrochloride

Vancomycin Hydrochloride

Daptomycin

Etrasimod

Other Products from this supplierMore>>

Other Products from this supplier
More>>